Mehdi Oualha

10.5k citations
90 papers · 1.2k indexed · h-index 18

Mehdi Oualha

81 papers receiving 1.1k citations

Peers

Mehdi Oualha
Comparison fields: 5 of 105
  • Applied Microbiology and Biotechnology 53
  • Critical Care and Intensive Care Medicine 100
  • Pharmacology 231
  • Molecular Medicine 63
  • Infectious Diseases 219
Replace Vasileios Karamouzos with:
Vasileios Karamouzos Greece
Pascal Augustin France
Tanıl Kendirli Türkiye
Brigitte Stoiser Austria
Fabrice Lesage France
Stefano Busani Italy
Jean‐Marie Conil France
Adrien Bouglé France
Sven Laudi Germany
Charles McDonald Australia
Mehdi Oualha relative to Vasileios Karamouzos Greece Vasileios Karamouzos's profile →
Citations per field
00.5×3.1×
Vasileios Karamouzos · 1×
Citations per year

Countries citing papers authored by Mehdi Oualha

Since Specialization
Citations

This map shows the geographic impact of Mehdi Oualha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Oualha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Oualha more than expected).

Fields of papers citing papers by Mehdi Oualha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Oualha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Oualha. The network helps show where Mehdi Oualha may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mehdi Oualha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mehdi Oualha Line = papers co-authored together Mehdi Oualha links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20240
4 20245
5 20235
6 20231
7 20231
8 20235
9 20224
10 20225
11 20226
12 20225
13 20212
14 20212
15 20214
16 2020223
17 202013
18 20177
19 20161
20 20130

About Mehdi Oualha

Mehdi Oualha is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology, having authored 90 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Pneumonia and Respiratory Infections (13 papers), Sepsis Diagnosis and Treatment (11 papers), Antibiotic Resistance in Bacteria (10 papers), Neonatal Health and Biochemistry (8 papers), Mechanical Circulatory Support Devices (7 papers), Metabolism and Genetic Disorders (6 papers) and Anesthesia and Sedative Agents (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (53 citations), Critical Care and Intensive Care Medicine (100 citations) and Pharmacology (231 citations). Mehdi Oualha has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Sylvain Renolleau, Fabrice Lesage, Jean‐Marc Tréluyer, Philippe Hubert, Florence Moulin, Sihem Benaboud, Marion Grimaud, Marianne Leruez‐Ville, Saı̈k Urien and Déborah Hirt. Their work appears in journals such as The Lancet, Journal of Clinical Microbiology and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026